Predictions
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€95.96
06.07.22
06.07.22
€120.00
06.07.23
06.07.23
-0.52%
30.05.23
30.05.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€87.46
05.07.22
05.07.22
€100.00
05.07.23
05.07.23
13.74%
06.07.23
06.07.23
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€94.96
07.06.22
07.06.22
€100.00
07.06.23
07.06.23
1.71%
08.06.23
08.06.23
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€102.90
31.05.22
31.05.22
€68.00
31.05.23
31.05.23
-38.37%
09.02.23
09.02.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€86.20
05.04.22
05.04.22
€100.00
01.09.22
01.09.22
19.37%
31.05.22
31.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€81.70
17.03.22
17.03.22
€105.00
17.03.23
17.03.23
-49.58%
23.09.22
23.09.22
Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€108.20
28.01.22
28.01.22
€130.00
28.01.23
28.01.23
-12.24%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€160.00
30.11.21
30.11.21
€200.00
31.12.24
31.12.24
-66.25%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Software AG
Start price
Target price
Perf. (%)
€36.48
19.10.21
19.10.21
-
19.10.22
19.10.22
-0.88%
13.11.21
13.11.21
Could be worthwhile Investment >10% per year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€123.90
04.10.21
04.10.21
-
04.10.22
04.10.22
-60.45%
05.10.22
05.10.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€120.30
06.08.21
06.08.21
-
06.08.22
06.08.22
-32.29%
13.03.22
13.03.22
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€132.40
08.07.21
08.07.21
-
08.07.22
08.07.22
-26.99%
08.07.22
08.07.22
Top 10 in its market
Well known brand
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€219.50
22.02.21
22.02.21
-
22.02.22
22.02.22
-28.06%
14.06.21
14.06.21
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€239.50
07.02.21
07.02.21
-
07.02.22
07.02.22
-38.71%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Innovative
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€199.00
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
-46.48%
17.01.22
17.01.22
Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€191.40
21.01.21
21.01.21
€200.00
4.49%
26.01.21
26.01.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€152.40
06.01.21
06.01.21
€200.00
16.80%
30.03.21
30.03.21
Medium risks for its business
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€162.60
16.10.20
16.10.20
€175.00
04.11.21
04.11.21
8.86%
20.01.21
20.01.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€135.80
08.09.20
08.09.20
€175.00
16.10.20
16.10.20
20.03%
16.10.20
16.10.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected